Therapeutic use of medical Cannabis in neurological diseases: a clinical update
Hidding U, Mainka T, Buhmann C
J NEURAL TRANSM. 2024;131(2):117-126.

Effect of subthalamic and nigral deep brain stimulation on speech and voice in Parkinson's patients
Müller F, Nienstedt J, Buhmann C, Hidding U, Gulberti A, Pötter-Nerger M, Pflug C
J NEURAL TRANSM. 2024 [Epub ahead of print].

Prospective controlled study on the effects of deep brain stimulation on driving in Parkinson's disease
Fründt O, Mainka T, Vettorazzi E, Baspinar E, Schwarz C, Südmeyer M, Gerloff C, Zangemeister W, Poetter-Nerger M, Hidding U, Hamel W, Moll C, Buhmann C
NPJ PARKINSONS DIS. 2023;9(1):105.

SAFE-DBS – A monocentric, randomised, blinded evaluation of safinamide in the perioperative period in Parkinsonian patients with deep brain stimulation
Gülke E, Höfs M, Pinnschmidt H, Gulberti A, Moll C, Hidding U, Buhmann C, Heise M, Hamel W, Pötter-Nerger M
MOVEMENT DISORD. 2023;38(Suppl 1):S608-S609.

Combined Short-Pulse and Directional Deep Brain Stimulation of the Thalamic Ventral Intermediate Area for Essential Tremor
Hidding U, Lezius S, Schaper M, Buhmann C, Gerloff C, Pötter-Nerger M, Hamel W, Moll C, Choe C
NEUROMODULATION. 2023;26(8):1680-1688.

Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson's disease
Gülke E, Alsalem M, Kirsten M, Vettorazzi E, Choe C, Hidding U, Zittel-Dirks S, Buhmann C, Schaper M, Gulberti A, Moll C, Hamel W, Koeppen J, Gerloff C, Pötter-Nerger M
PLOS ONE. 2022;17(4):.

Multisystemic neurodegeneration caused by biallelic pentanucleotide expansions in RFC1
Herrmann L, Gelderblom M, Bester M, Deininger N, Schütze T, Hidding U, Gross C, Buena-Atienza E, Dufke C, Gerloff C, Haack T, Zittel S
PARKINSONISM RELAT D. 2022;95:54-56.

Short pulse and directional thalamic deep brain stimulation have differential effects in parkinsonian and essential tremor
Hidding U, Schaper M, Gulberti A, Buhmann C, Gerloff C, Moll C, Hamel W, Choe C, Pötter-Nerger M
SCI REP-UK. 2022;12(1):.

Comparison of Shod and Unshod Gait in Patients With Parkinson's Disease With Subthalamic and Nigral Stimulation: Footwear and STN+SN-DBS in PD
Horn M, Gulberti A, Hidding U, Gerloff C, Hamel W, Moll C, Pötter-Nerger M
FRONT HUM NEUROSCI. 2022;15:.

Retrospektive Langzeitdaten von Patienten mit Parkinsonsyndrom nach STN-THS Implantation mit segmentierten Elektroden: Real-world long-term data of patients with Parkinson’s disease after STN-DBS with segmented electrodes
Kirsten M, Schoenfeldt-Reichmann E, Gulberti A, Gülke E, Hidding U, Buhmann C, Hamel W, Moll C, Gerloff C, Pötter-Nerger M
2022. Deutscher Parkinson Kongress 2022. .

Cannabis in Parkinson's Disease: The Patients' View
Yenilmez F, Fründt O, Hidding U, Buhmann C
J PARKINSON DIS. 2021;11(1):309-321.

Dopamine boosts intention and action awareness in Parkinson's disease
Di Costa S, Barow E, Hidding U, Mainka T, Pötter-Nerger M, Buhmann C, Moll C, Haggard P, Ganos C
EXP BRAIN RES. 2020;238(9):1989-1995.

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson's disease
Pflug C, Nienstedt J, Gulberti A, Müller F, Vettorazzi E, Koseki J, Niessen A, Flügel T, Hidding U, Buhmann C, Weiss D, Gerloff C, Hamel W, Moll C, Pötter-Nerger M
ANN CLIN TRANSL NEUR. 2020;7(5):628-638.

Pallidal lead placement in dystonia: leads of non-responders are contained within an anatomical range defined by responders
Zittel S, Hidding U, Trumpfheller M, Baltzer V, Gulberti A, Schaper M, Biermann M, Buhmann C, Engel A, Gerloff C, Westphal M, Stadler J, Köppen J, Pötter-Nerger M, Moll C, Hamel W
J NEUROL. 2020;267(6):1663-1671.

Pill swallowing in Parkinson's disease: A prospective study based on flexible endoscopic evaluation of swallowing
Buhmann C, Bihler M, Emich K, Hidding U, Pötter-Nerger M, Gerloff C, Niessen A, Flügel T, Koseki J, Nienstedt J, Pflug C
PARKINSONISM RELAT D. 2019;62:51-56.

Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration?
Buhmann C, Flügel T, Bihler M, Gerloff C, Nießen A, Hidding U, Nienstedt J, Pflug C
PARKINSONISM RELAT D. 2019;61:138-143.

IRF2BPL mutations cause autosomal dominant dystonia with anarthria, slow saccades and seizures
Ganos C, Zittel S, Hidding U, Funke C, Biskup S, Bhatia K
PARKINSONISM RELAT D. 2019;68:57-59.

Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease
Hidding U, Gulberti A, Pflug C, Choe C, Horn A, Prilop L, Braaß H, Fründt O, Buhmann C, Weiss D, Westphal M, Engel A, Gerloff C, Köppen J, Hamel W, Moll C, Pötter-Nerger M
PARKINSONISM RELAT D. 2019;62:141-147.

Mapping stimulation-induced beneficial and adverse effects in the subthalamic area of essential tremor patients
Hidding U, Schaper M, Moll C, Gulberti A, Köppen J, Buhmann C, Gerloff C, Pötter-Nerger M, Hamel W, Choe C
PARKINSONISM RELAT D. 2019;64:150-155.

Voluntary inhibition of involuntary groaning in progressive supranuclear palsy
Mainka T, Hidding U, Buhmann C, Haggard P, Ganos C
MOV DISORD CLIN PRAC. 2019;5(3):325-326.

Thalamic short pulse stimulation diminishes adverse effects in essential tremor patients
Choe C, Hidding U, Schaper M, Gulberti A, Köppen J, Buhmann C, Gerloff C, Moll C, Hamel W, Pötter-Nerger M
NEUROLOGY. 2018;91(8):e704-e713.

Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature
Engel K, Huckhagel T, Gulberti A, Pötter-Nerger M, Vettorazzi E, Hidding U, Choe C, Zittel S, Braaß H, Ludewig P, Schaper M, Krajewski K, Oehlwein C, Mittmann K, Engel A, Gerloff C, Westphal M, Moll C, Buhmann C, Köppen J, Hamel W
PLOS ONE. 2018;13(8):e0198529.

Cannabis bei Parkinson – Hype oder Heilmittel
Mainka T, Stork J, Hidding U, Buhmann C
FORTSCHR NEUROL PSYC. 2018;86(2):106-116.

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study
McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L
J HUNTINGTONS DIS. 2018;7(3):209-222.

Critical Dysphagia is Common in Parkinson Disease and Occurs Even in Early Stages: A Prospective Cohort Study
Pflug C, Bihler M, Emich K, Niessen A, Nienstedt J, Flügel T, Koseki J, Plaetke R, Hidding U, Gerloff C, Buhmann C
DYSPHAGIA. 2018;33(1):41-50.

Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum
Schreglmann S, Riederer F, Galovic M, Ganos C, Kägi G, Waldvogel D, Jaunmuktane Z, Schaller A, Hidding U, Krasemann E, Michels L, Baumann C, Bhatia K, Jung H
MOVEMENT DISORD. 2018;33(1):146-155.

How does it feel to be operated on the brain? Perceived intraoperative stress of movement disorder patients undergoing awake deep brain stimulation surgery
Sieger J, Gulberti A, Köppen J, Pinnschmidt H, Nitzschke R, Schaper M, Braaß H, Buhmann C, Choe C, Hidding U, Zittel S, Engel A, Mehnert A, Gerloff C, Westphal M, Pötter-Nerger M, Hamel W, Moll C
2018. The many faces of Parkinson’s disease – Motor and non ‐ motor symptoms from prodromal to advanced disease stages. .

First report of clinical outcomes resulting from use of directional deep brain stimulation in Parkinson's disease and essential tremor
Braaß H, Venkatesan , Choe C, Hidding U, Schönwald B, Wargel C, Buhmann C, Gulberti A, Moll C, Köppen J, Gerloff C, Hamel W, Pötter-Nerger M
2017. Mov Disord . suppl. ed. .

Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences
Buhmann C, Huckhagel T, Engel K, Gulberti A, Hidding U, Poetter-Nerger M, Goerendt I, Ludewig P, Braass H, Choe C, Krajewski K, Oehlwein C, Mittmann K, Engel A, Gerloff C, Westphal M, Köppen J, Moll C, Hamel W
PLOS ONE. 2017;12(7):e0178984.

Impact of combined subthalamic nucleus and substantia nigra stimulation on neuropsychiatric symptoms in Parkinson’s disease patients
Hidding U, Gulberti A, Horn A, Buhmann C, Hamel W, Köppen J, Westphal M, Engel A, Gerloff C, Weiss D, Moll C, Pötter-Nerger M
PARKINSONS DIS-US. 2017;2017:7306192.

Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry
Stemplewitz B, Kromer R, Vettorazzi E, Hidding U, Frings A, Buhmann C
SCI REP-UK. 2017;7(1):5357.

The impact of Parkinson disease on patients´ sexuality and relationship
Buhmann C, Dogac S, Vettorazzi E, Hidding U, Gerloff C, Jürgens T
J NEURAL TRANSM. 2016;124(8):983-996.

Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography
Kromer R, Buhmann C, Hidding U, Keserü M, Bittersohl D, Hassenstein A, Stemplewitz B
PLOS ONE. 2016;11(8):e0161136.

Wie hilfreich ist High-Tech? Entwicklungen der Tiefen Hirnstimulation bei der Parkinson-Krankheit
Pötter-Nerger M, Moll C, Gulberti A, Hamel W, Köppen J, Ludewig P, Hidding U, Goerendt I, Gerloff C, Buhmann C
Neuro aktuell. 2015;(7):21-25.

Tiefe Hirnstimulation: Neurophysiologische Therapie bei M. Parkinson und anderen neurologischen Erkrankungen. Ablauf und Ergebnisse
Goerendt I, Moll C, Fickel U, Gerloff C, Gulberti A, Hidding U, Köppen J, Pötter-Nerger M, Engel A, Westphal M, Buhmann C, Hamel W
Hamb Ärztebl. 2014;68(01):12-17.

Wann sind Pflaster, Pens oder Pumpen eine sinnvolle Ergänzung zur oralen Therapie?
Pötter-Nerger M, Ludewig P, Hidding U, Goerendt I, Gerloff C, Buhmann C
Info Neurol Psych. 2014;16(12):42-53.

Mere surgery will not cure cluster headache--implications for neurostimulation.
Hidding U, May A
CEPHALALGIA. 2011;31(1):112-115.

Entrainment of STN neurons by cortical beta oscillations in Parkinson's disease
Sharott A, Gulberti A, Hamel W, Köppen J, Zittel S, Hidding U, Gerloff C, Westphal M, Engel A, Moll C
2009. 2009 Neuroscience Meeting Planner. .

Pallidal neuronal activity in myoclonus-dystonia syndrome
Gulberti A, Moll C, Sharott A, Hamel W, Muenchau A, Buhmann C, Hidding U, Zittel S, Gerloff C, Westphal M, Müller D, Engel A
2007. IBAGS IX. .

arousal reaction due to electrical stimulation of the globus pallidus
Moll C, Sharrott A, Buhmann C, Hidding U, Zittel S, Westphal M, Hamel W, Engel A
ACTA PHYSIOL. 2007;189.

MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
Hidding U, Bäumer T, Siebner H, Demiralay C, Buhmann C, Weyh T, Moll C, Hamel W, Münchau A
MOVEMENT DISORD. 2006;21(9):1471-1476.

Letzte Aktualisierung aus dem FIS: 30.11.2024 - 03:50 Uhr